肺外CT表现预测COVID-19患者院内死亡:系统综述与荟萃分析
该系统综述与荟萃分析检索截至2021年6月的MEDLINE、Cochrane和SCOPUS数据库,纳入22项研究共7859例COVID-19患者,评估肺外胸部CT表现与院内死亡的关系。结果显示胸腔积液、冠脉钙化和纵隔淋巴结肿大与院内死亡相关,心包积液的合并OR未达统计学显著。
要点
- 胸腔积液合并OR 4.60(95%CI 2.97-7.12),与COVID-19院内死亡相关。
- 冠脉钙化合并OR 2.68(95%CI 1.78-4.04),与院内死亡相关。
- 纵隔淋巴结肿大合并OR 2.02(95%CI 1.18-3.45),心包积液OR 1.29(95%CI 0.83-1.98)未达显著。
核心结论
- 胸腔积液、纵隔淋巴结肿大和冠脉钙化与COVID-19患者院内死亡有相关关联,应作为预后生物标志物纳入临床常规。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Cochrane和SCOPUS数据库截至2021年6月,纳入22项研究共7859例患者,汇总4项肺外CT表现。
关键影像表现/征象
- 汇总的肺外CT表现包括胸腔积液、心包积液、纵隔淋巴结肿大和冠脉钙化。
- 胸腔积液对院内死亡的合并OR为4.60(95%CI 2.97-7.12)。
- 冠脉钙化对院内死亡的合并OR为2.68(95%CI 1.78-4.04)。
- 纵隔淋巴结肿大对院内死亡的合并OR为2.02(95%CI 1.18-3.45)。
- 心包积液对院内死亡的合并OR为1.29(95%CI 0.83-1.98),未达统计学显著。
临床应用与阅片要点
- 作者认为胸腔积液、纵隔淋巴结肿大和冠脉钙化应作为预后生物标志物纳入临床常规。
- 阅片时可关注这四项肺外CT表现,结合临床评估COVID-19患者院内死亡风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Several prognostic factors have been identified for COVID-19 disease. Our aim was to elucidate the influence of non-pulmonary findings of thoracic computed tomography (CT) on unfavorable outcomes and in-hospital mortality in COVID-19 patients based on a large patient sample.
MATERIALS AND METHODS: MEDLINE library, Cochrane and SCOPUS databases were screened for the associations between CT-defined features and mortality in COVID-19 patients up to June 2021. In total, 22 studies were suitable for the analysis, and included into the present analysis. Overall, data regarding 4 extrapulmonary findings could be pooled: pleural effusion, pericardial effusion, mediastinal lymphadenopathy, and coronary calcification.
RESULTS: The included studies comprised 7859 patients. The pooled odds ratios for the effect of the identified extrapulmonary findings on in-hospital mortality are as follows: pleural effusion, 4.60 (95% CI 2.97-7.12); pericardial effusion, 1.29 (95% CI 0.83-1.98); coronary calcification, 2.68 (95% CI 1.78-4.04); mediastinal lymphadenopathy, 2.02 (95% CI 1.18-3.45).
CONCLUSION: Pleural effusion, mediastinal lymphadenopathy and coronary calcification have a relevant association with in-hospital mortality in COVID-19 patients and should be included as prognostic biomarker into clinical routine.
引用
- Meyer HJ, Wienke A, Surov A, et al. Extrapulmonary CT Findings Predict In-Hospital Mortality in COVID-19. A Systematic Review and Meta-Analysis. Acad Radiol. 2021. PMID: 34772618. doi:10.1016/j.acra.2021.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。